Julia Kirchheiner
Institute of Clinical Pharmacology
Humboldt University
Berlin
Germany
Name/email consistency: high
- Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets. Kirchheiner, J., Henckel, H.B., Franke, L., Meineke, I., Tzvetkov, M., Uebelhack, R., Roots, I., Brockmöller, J. Pharmacogenet. Genomics (2005)
- Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?. Kirchheiner, J., Fuhr, U., Brockmöller, J. Nat. Rev. Drug. Discov (2005)
- Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. Kirchheiner, J., Roots, I., Goldammer, M., Rosenkranz, B., Brockmöller, J. Clin. Pharmacokinet (2005)
- Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Kirchheiner, J., Heesch, C., Bauer, S., Meisel, C., Seringer, A., Goldammer, M., Tzvetkov, M., Meineke, I., Roots, I., Brockmöller, J. Clin. Pharmacol. Ther. (2004)